Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry

Keyphrases

• Autologous Transplantation 7%
• B Cells 7%
• B Lymphocytes 100%
• CD138 7%
• CD184 7%
• CD19 14%
• CD20 7%
• CD31 7%
• CD34 14%
• CD38 7%
• CD50 7%
• Clonal Rearrangements 7%
• Clonality 7%
• Clonality Analysis 7%
• Complementarity-determining Region 3 (CDR3) 14%
• Cryopreserved 7%
• Drug-resistant Tumor 7%
• Flow Cytometry 100%
• Gene Rearrangement 7%
• IGH Rearrangement 7%
• Immunoglobulin Light Chains 14%
• Immunophenotyping 21%
• Light Chain 14%
• Light Surfaces 7%
• Lymphocytes 7%
• Multiple Myeloma 100%
• Myeloma 35%
• Myeloma Cells 21%
• Neoplastic Plasma Cells 7%
• Peripheral Blood 7%
• Peripheral Blood Stem Cells 7%
• Polymerase Chain Reaction 7%
• Progenitor Cells 7%
• Remission Rate 7%
• Same Patient 7%
• Stem Cell Harvest 7%
• Therapy-resistant 7%

Medicine and Dentistry

• B Cell 7%
• B Lymphocyte 100%
• CD20 7%
• Clonal Variation 14%
• Flow Cytometry 100%
• Gene Rearrangement 7%
• Immunoglobulin Light Chain 14%
• Immunoglobulin Producing Cell 7%
• Immunophenotyping 21%
• Light Chain 14%
• Lymphocyte 7%
• Multiple Myeloma 100%
• Myeloma 35%
• Myeloma Cell 21%
• Neoplasm 7%
• Peripheral Blood Stem Cell 7%
• Polymerase Chain Reaction 7%
• Progenitor Cell 7%
• Recurrent Disease 7%
• Spontaneous Remission 7%
• Stem Cell 7%

Immunology and Microbiology

• B Cell 100%
• CD19 13%
• CD20 6%
• CD31 6%
• CD34 13%
• CD38 6%
• Clonal Variation 13%
• Gene Rearrangement 6%
• Immunoglobulin Light Chain 13%
• Immunoglobulin Producing Cell 6%
• Light Chain 13%
• Lymphocyte 6%
• Multiple Myeloma 100%
• Myeloma Cell 20%
• Peripheral Blood Stem Cell 6%
• Polymerase Chain Reaction 6%
• Stem Cell 6%